71 related articles for article (PubMed ID: 19494841)
21. Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy.
Roschewski M; Hodson DJ
Haematologica; 2024 Feb; 109(2):388-400. PubMed ID: 37706315
[TBL] [Abstract][Full Text] [Related]
22. Primary central nervous system lymphoma.
Ferreri AJM; Calimeri T; Cwynarski K; Dietrich J; Grommes C; Hoang-Xuan K; Hu LS; Illerhaus G; Nayak L; Ponzoni M; Batchelor TT
Nat Rev Dis Primers; 2023 Jun; 9(1):29. PubMed ID: 37322012
[TBL] [Abstract][Full Text] [Related]
23. Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts.
Kurz KS; Ott M; Kalmbach S; Steinlein S; Kalla C; Horn H; Ott G; Staiger AM
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190213
[TBL] [Abstract][Full Text] [Related]
24. Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
Zhu Q; Wang J; Zhang W; Zhu W; Wu Z; Chen Y; Chen M; Zheng L; Tang J; Zhang S; Wang D; Wang X; Chen G
Front Genet; 2022; 13():878618. PubMed ID: 35646048
[No Abstract] [Full Text] [Related]
25. The genomic and transcriptional landscape of primary central nervous system lymphoma.
Radke J; Ishaque N; Koll R; Gu Z; Schumann E; Sieverling L; Uhrig S; Hübschmann D; Toprak UH; López C; Hostench XP; Borgoni S; Juraeva D; Pritsch F; Paramasivam N; Balasubramanian GP; Schlesner M; Sahay S; Weniger M; Pehl D; Radbruch H; Osterloh A; Korfel A; Misch M; Onken J; Faust K; Vajkoczy P; Moskopp D; Wang Y; Jödicke A; Trümper L; Anagnostopoulos I; Lenze D; Küppers R; Hummel M; Schmitt CA; Wiestler OD; Wolf S; Unterberg A; Eils R; Herold-Mende C; Brors B; ; Siebert R; Wiemann S; Heppner FL
Nat Commun; 2022 May; 13(1):2558. PubMed ID: 35538064
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Patient-Specific Human Leukocyte Antigen Genomic Loss at Relapse After Antithymocyte Globulin-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplant.
Wu H; Shi J; Luo Y; Yu J; Lai X; Liu L; Fu H; Ouyang G; Xu X; Xiao H; Huang H; Zhao Y
JAMA Netw Open; 2022 Apr; 5(4):e226114. PubMed ID: 35385089
[TBL] [Abstract][Full Text] [Related]
27. Impact of a Faulty Germinal Center Reaction on the Pathogenesis of Primary Diffuse Large B Cell Lymphoma of the Central Nervous System.
Montesinos-Rongen M; Brunn A; Sanchez-Ruiz M; Küppers R; Siebert R; Deckert M
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944954
[TBL] [Abstract][Full Text] [Related]
28. Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing.
Gao F; Tian L; Shi H; Zheng P; Wang J; Dong F; Hu K; Ke X
Front Genet; 2021; 12():677650. PubMed ID: 34925435
[TBL] [Abstract][Full Text] [Related]
29. Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma.
Wirsching HG; Weller M; Balabanov S; Roth P
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34203062
[TBL] [Abstract][Full Text] [Related]
30. TOX as a potential target for immunotherapy in lymphocytic malignancies.
Liang C; Huang S; Zhao Y; Chen S; Li Y
Biomark Res; 2021 Mar; 9(1):20. PubMed ID: 33743809
[TBL] [Abstract][Full Text] [Related]
31. Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key Histomorphologic, Immunophenotypic, and Genetic Features.
Lauw MIS; Lucas CG; Ohgami RS; Wen KW
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33322508
[TBL] [Abstract][Full Text] [Related]
32. EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.
Gandhi MK; Hoang T; Law SC; Brosda S; O'Rourke K; Tobin JWD; Vari F; Murigneux V; Fink L; Gunawardana J; Gould C; Oey H; Bednarska K; Delecluse S; Trappe RU; Merida de Long L; Sabdia MB; Bhagat G; Hapgood G; Blyth E; Clancy L; Wight J; Hawkes E; Rimsza LM; Maguire A; Bojarczuk K; Chapuy B; Keane C
Blood; 2021 Mar; 137(11):1468-1477. PubMed ID: 33202420
[TBL] [Abstract][Full Text] [Related]
33. Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment.
Cai Q; Fang Y; Young KH
Transl Oncol; 2019 Mar; 12(3):523-538. PubMed ID: 30616219
[TBL] [Abstract][Full Text] [Related]
34. Introduction of novel agents in the treatment of primary CNS lymphoma.
Grommes C; Nayak L; Tun HW; Batchelor TT
Neuro Oncol; 2019 Feb; 21(3):306-313. PubMed ID: 30423172
[TBL] [Abstract][Full Text] [Related]
35. Target amplicon exome-sequencing identifies promising diagnosis and prognostic markers involved in RTK-RAS and PI3K-AKT signaling as central oncopathways in primary central nervous system lymphoma.
Takashima Y; Sasaki Y; Hayano A; Homma J; Fukai J; Iwadate Y; Kajiwara K; Ishizawa S; Hondoh H; Tokino T; Yamanaka R
Oncotarget; 2018 Jun; 9(44):27471-27486. PubMed ID: 29937999
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and biology of relapse after stem cell transplantation.
Horowitz M; Schreiber H; Elder A; Heidenreich O; Vormoor J; Toffalori C; Vago L; Kröger N
Bone Marrow Transplant; 2018 Nov; 53(11):1379-1389. PubMed ID: 29670211
[No Abstract] [Full Text] [Related]
37. Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma.
Bruno A; Labreche K; Daniau M; Boisselier B; Gauchotte G; Royer-Perron L; Rahimian A; Lemoine F; de la Grange P; Guégan J; Bielle F; Polivka M; Adam C; Meyronet D; Figarella-Branger D; Villa C; Chrétien F; Eimer S; Davi F; Rousseau A; Houillier C; Soussain C; Mokhtari K; Hoang-Xuan K; Alentorn A
Neuro Oncol; 2018 Jul; 20(8):1092-1100. PubMed ID: 29432597
[TBL] [Abstract][Full Text] [Related]
38. Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia.
Reina-Castillón J; Pujol R; López-Sánchez M; Rodríguez-Santiago B; Aza-Carmona M; González JR; Casado JA; Bueren JA; Sevilla J; Badel I; Català A; Beléndez C; Dasí MÁ; Díaz de Heredia C; Soulier J; Schindler D; Pérez-Jurado LA; Surrallés J
Blood Adv; 2017 Jan; 1(5):319-329. PubMed ID: 29296947
[TBL] [Abstract][Full Text] [Related]
39. Biology of CNS lymphoma and the potential of novel agents.
Rubenstein JL
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):556-564. PubMed ID: 29222305
[TBL] [Abstract][Full Text] [Related]
40. Advances in Pathobiology of Primary Central Nervous System Lymphoma.
Yang XL; Liu YB
Chin Med J (Engl); 2017 Aug; 130(16):1973-1979. PubMed ID: 28776551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
